Catalyst Event
Ionis Pharmaceuticals Inc (IONS) · Earnings Release
From KEDI Global Longevity Bio Index (KGLB)
4/29/2026, 12:00:00 AM
Ionis reported Q1 2026 revenue of $246 million, beating estimates, and narrowed its net loss; the company also raised its full-year 2026 revenue guidance to $875-$900 million. This is estimated to have a >10% price impact due to the significant guidance raise, so the earnings release is expected.
Korean Translation
2026년 1분기 매출 2억 4,600만 달러를 보고하여 예상치를 상회했으며 순손실은 감소함. 또한 2026년 연간 매출 가이던스를 8억 7,500만~9억 달러로 상향 조정함. 가이던스 상향으로 인해 10% 이상의 주가 영향이 예상됨.
Related Recent Events
Biogen Inc (BIIB) · Other
FDA PDUFA target action date for LEQEMBI's subcutaneous autoinjector formulation (IQLIK SC-AI) for initiation dosing, a potential new administration option for the Alzheimer's disease treatment, scheduled for 2026-05-24. High impact expected due to the significant market potential of the Alzheimer's treatment.
5/24/2026, 12:00:00 AM
Thermo Fisher Scientific Inc (TMO) · Other
An Investor Day is scheduled for May 20, 2026, where senior management will provide presentations scheduled.
5/20/2026, 12:00:00 AM
Takeda Pharmaceutical Co Ltd (TAK) · Earnings Release
Takeda is scheduled to announce its financial results for the full fiscal year 2025 (ending March 31, 2026) on May 13, 2026. High importance is estimated as earnings reports for major pharmaceutical firms often trigger price movements exceeding 10% based on guidance. This event is scheduled.
5/13/2026, 12:00:00 AM
Natera Inc (NTRA) · Earnings Release
Q1 2026 earnings release is scheduled. Earnings announcements typically result in >5% price impact, scheduled.
5/7/2026, 12:00:00 AM
Viatris Inc (VTRS) · Earnings Release
Viatris is scheduled to report its first quarter 2026 financial results on May 7, 2026, with an estimated price impact of over 5% based on historical earnings volatility scheduled.
5/7/2026, 12:00:00 AM
Novo Nordisk A/S (NVO) · Earnings Release
Novo Nordisk is scheduled to announce its first quarter 2026 financial results. Low importance as it is a routine earnings call, scheduled.
5/6/2026, 12:00:00 AM